Question from Deputy Ken O'Flynn - PQ 36573-26
Deputy O'Flynn asked about fraud-risk assessments and expenditure-risk scoring for the Treatment Abroad Scheme. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about fraud-risk assessments and expenditure-risk scoring for the Treatment Abroad Scheme. Read the HSE response.
Deputy O'Flynn asked about a cost analysis of procedures funded under the Treatment Abroad Scheme. Read the HSE response.
Deputy O'Flynn asked about the HSE Mental Health Services Key Performance Indicator Metadata document. Read the HSE response.
Deputy O'Flynn asked how many medicinal products received reimbursement price uplifts under PCRS arrangements from 2020 to 2026. Read the HSE response.
Deputy O'Flynn asked about a centralised register categorising Treatment Abroad Scheme approvals. Read the HSE response.
Deputy Byrne asked about the average wait time for a first appointment with National Counselling Service (NCS ) in each county. Read the HSE response.
Deputy O'Flynn asked about the guidance issued by the HSE to individuals in areas where manganese levels exceed 50 µg/l. Read the HSE response.
Deputy O'Flynn asked about approving overseas procedures in the absence of a nationally agreed definition of "medical necessity". Read the HSE response.
Deputy O'Flynn asked about a national consistency review for the Treatment Abroad Scheme. Read the HSE response.
Deputy O'Flynn asked about the projected total cost of the National Laboratory Information System (MedLIS). Read the HSE response.